BizDev.

Investing in Innovation (i3) Africa

Who are we Looking For?

i3’s current work seeks to catalyze the development of early- and growth-stage ventures building data-driven access to healthcare.

We seek to focus our impact on innovations that stand to benefit Africa, therefore we target program participants whose companies are owned, led or operated by African citizens and produce products for African customers.

UPDATE, Jan 28th.

On Jan 25th, the US government issued a ‘stop work’ directive for US aid, intensifying the need for locally-driven, market-creating approaches to health product distribution and service delivery across Africa.

In response, i3 has taken the decision to prioritize immediate support for 5-7 growth-stage companies building the Future of Pharmacy care in Africa, increasing efforts to help these innovative companies rapidly expand access to patient care.

Thus, i3 is only selecting growth-stage companies focused on the Future of Pharmacy at this time. We aim to support to a set of early-stage companies at a later date. Please sign up for our newsletter to stay in touch.

 

 

Innovators must fulfill the criteria below to qualify for review in i3’s 3rd cohort:

FOCUS ON AFRICA

  • Must have a strategic focus on meeting the needs of African customers in Africa.
  • Must be headquartered or have a legal presence in Africa.

 

FOCUS ON THE FUTURE OF PHARMACY CARE

  • Must offer advanced tech-enabled solutions aimed at improving pharmacy services. Innovators that develop novel health products or devices as a part of their delivery or distribution services are eligible. Excluded are innovators who are solely focused on research, education, and product or device development. The business does not need to be solely focused on health to be eligible.
  • Non-profits, consultancies, intermediaries and consortiums are not eligible.

 

BE AT THE GROWTH STAGE, SEEKING HEALTHCARE PARTNERSHIPS

Nascent/idea stage companies are not eligible. Mature companies (incumbents) are not eligible. To be considered “growth stage” innovators must meet at least 5 of the criteria below:

  • Products/ services in market at/near national scale in at least one country
  • Strong, well-defined revenue model, sales and operational capabilities
  • Decreasing customer acquisition costs
  • Proven customer and revenue diversification with aggregate annual revenues over $500K USD
  • Clear plan for businesses growth and sustainability
  • Clear plan for growth of healthcare offering
  • Needs in healthcare growth plan that correspond to i3’s offerings

 

IMPACT PATIENT ACCESS

The business does not need to be solely focused on health.

Innovators must demonstrate that grant funding will generate direct improvements in one or more of the following areas: availability, accessibility, quality, affordability or visibility of critical health products and services.

About

NextBillion publishes free ads for business development opportunities available to enterprises working in low- and middle-income countries. These may include accelerators, competitions, funding opportunities, incubators, requests for proposals, and training courses. To submit an ad, click on the “Submit BizDev Opportunity” button above.
 

Connect

The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
No Thanks
Thank you for signing up to receive the NextBillion Notes newsletter.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.
×
×